Physician profile
Jonathan N Rubenstein
NPI 1720035116
$14,942.43
in general payments reported to CMS, 2019-2025
58 companies · $2,352 in 2025
The $2,352 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,421 · 2020: $387 · 2021: $1,024 · 2022: $1,537 · 2023: $1,908 · 2024: $2,314 · 2025: $2,352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,461 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,461.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $111.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,590.15 | 2019-2025 | Lupron Depot |
| Sumitomo Pharma America, INC. | $1,309.69 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $1,098.52 | 2019-2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $799.37 | 2019-2025 | |
| Astellas Pharma US INC | $726.24 | 2019-2024 | Myrbetriq |
| Pfizer INC. | $550.28 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $506.89 | 2019-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $380.82 | 2019-2024 | Provenge |
| Progenics Pharmaceuticals, INC. | $330.24 | 2023-2025 | Pylarify |
| Olympus America INC. | $320.87 | 2021-2025 | Itind System, Soltive |
| Teleflex LLC | $316.00 | 2022-2025 | Urolift, Barrigel |
| Merck Sharp & Dohme LLC | $280.78 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Allergan, INC. | $273.58 | 2019-2021 | |
| Urovant Sciences INC | $257.91 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $253.36 | 2019-2024 | Xiaflex, Aveed |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $210.45 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $209.46 | 2019-2025 | |
| Sn Holdings, LLC | $183.00 | 2023 | |
| Novartis Pharmaceuticals Corporation | $175.62 | 2023-2025 | |
| Myovant Sciences INC. | $161.53 | 2021-2022 | |
| Immunitybio, INC. | $158.40 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $151.60 | 2024 | Bard Urinary Drainage Bag |
| Endo USA, INC. | $151.16 | 2024-2025 | Aveed, Xiaflex |
| Accord Healthcare, INC. | $134.48 | 2023-2024 | |
| Antares Pharma, INC. | $129.72 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Urogen Pharma, INC. | $129.16 | 2022-2025 | |
| Blue Earth Diagnostics | $114.46 | 2019-2025 | Posluma |
| Janssen Scientific Affairs, LLC | $96.23 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $84.94 | 2024-2025 | Opdivo |
| Tolmar, INC. | $79.56 | 2023-2025 | Eligard, Jatenzo |
| Boston Scientific Corporation | $74.64 | 2021-2025 | Ams 700 |
| Halozyme INC | $68.66 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $68.63 | 2022-2025 | Lynparza |
| Novo Nordisk INC | $67.30 | 2024 | Rivfloza |
| Bioprotect Medical, INC. | $43.86 | 2025 | Bioprotect Balloon Implant System |
| Glaukos Corporation | $39.28 | 2023 | |
| Myriad Genetic Laboratories, INC. | $38.74 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $38.29 | 2025 | Trelstar |
| Tempus Ai, INC | $35.62 | 2024-2025 | Xt Cdx |
| Calyxo, INC. | $35.19 | 2025 | Cvac Aspiration System |
| Medtronic, INC. | $34.51 | 2022 | |
| Convatec INC. | $29.04 | 2021 | |
| Amgen INC. | $25.59 | 2019 | |
| Clarus Therapeutics INC. | $20.77 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $19.24 | 2025 | |
| Rochester Medical Corporation | $18.93 | 2021 | |
| Caris Mpi, INC. | $18.22 | 2025 | Mi Cancer Seek |
| Travere Therapeutics, INC. | $17.36 | 2019 | |
| Civco Medical Instruments | $16.06 | 2025 | |
| Laborie Medical Technologies Corp. | $14.47 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Foundation Medicine, INC. | $13.82 | 2021 | |
| Palette Life Sciences, INC. | $13.51 | 2022 | |
| Coloplast Corp | $13.43 | 2024 | |
| Acerus Pharmaceuticals Corporation | $12.80 | 2022 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$361,837.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Rubenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.